Thursday, October 1, 2020

 

Web Of 'Wellness' Doctors Promote Injections Of Unproven ...

18 hours ago - compounding pharmacy might make a version of a drug for a patient with an ... for COVID-19 based in Michigan, Tennessee, Texas, Florida, Iowa, New York, ..

Courts Reject Demands to Force FDA to Approve Hydroxychloroquine for COVID-19 October 1, 2020 By Anne K. Walsh —

https://www.fdalawblog.net/2020/10/courts-reject-demands-to-force-fda-to-approve-hydroxychloroquine-for-covid-19/ 

Very Important and Informative Slides Relating to Compounded Animal Drugs


Animal Drug Compounding Market to Reach $1.4B by 2024: April 2017: Persistence Market ... cisapride which was taken off the market for humans many years.

 

Coronavirus (COVID-19) Update: Daily Roundup October 1, 2020

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

  • Today, the FDA revised its Emergency Use Authorization (EUA) to reflect changes in the distribution and allocation of the antiviral drug Veklury (remdesivir). More information about the revised EUA can be found here.
  • The FDA has issued a warning letter to Kerri Rivera and her company KetoKerri, LLC, for the sale of unapproved and misbranded drugs related to the Coronavirus. Products “KK Black Seed Oil,” “KK Breakthrough Vitamin D with Chondroitin & Oleic”, “Stonebreaker,” “KK EDTA with Selenium and Minerals,” “Zeolite,” “Ultra Liquid Zeolite,” and “DR. FITT FIRE FIGHTERS” make fraudulent claims to mitigate, prevent, treat, or cure COVID-19 in people. The products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a), and are also misbranded under section 502 of the FD&C Act, 21 U.S.C. § 352.
  • Testing updates:
    • As of today, 265 tests are authorized by FDA under EUAs; these include 210 molecular tests, 51 antibody tests, and 4 antigen tests.

 

USDA and FDA Sign Memorandum of Understanding to Enhance Collaboration, Efficiency on U.S. Dairy Exports

Today, the United States Department of Agriculture (USDA) and the United States Food and Drug Administration (FDA) signed a Memorandum of Understanding (MOU) outlining strengthened coordination between the FDA and the USDA’s Agricultural Marketing Service (AMS) and Foreign Agricultural Service (FAS) to facilitate the export of milk and milk products from the United States. U.S. dairy exports are valued at nearly $6 billion annually.

“The rising trend by trading partners requesting additional information and assurances from dairy exporters requires an exceptional level of coordination by government authorities to address and facilitate requests,” said Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. “This MOU reflects a concerted, modern approach to leverage our collective strengths as we move into a New Era of Smarter Food Safety.”

“Signing the MOU is an important milestone in the continued collaboration between USDA and FDA,” stated USDA Under Secretary Greg Ibach, Marketing and Regulatory Programs. “With the MOU in place, USDA and FDA have clearly defined the critical functions needed to assist the dairy industry to improve efficiency and effectiveness by focusing on the core competencies of each agency to engage on certain issues.” 

USDA Under Secretary for Trade and Foreign Agricultural Affairs Ted McKinney said, “This MOU will help USDA and FDA address the challenges faced by...

Read More Button


Trump boasted he made insulin so cheap “it’s like water.” Diabetics beg to differ.
The president said at Tuesday’s debate that he lowered insulin prices. That’s not true — and, for some, the drug’s expense is a fatal barrier.

Read in The Washington Post: https://apple.news/AHMR4gKnrTNiSOri37LL4Dw

 

Recent Animal Drug Approvals

The FDA’s Center for Veterinary Medicine has updated its Recent Animal Drug Approvals page to reflect the September approvals of New Animal Drug Application 141-529 and Abbreviated New Animal Drug Applications 200-069, 200-528 and 200-690.

Read More

 

Medicaid, CHIP enrollment grew by 4 million during COVID-19

Medicaid and CHIP enrollment grew from almost 71 million people in February to nearly 75 million in June, according to a CMS report. Nearly all states saw their Medicaid rolls grow.

READ MORE >

The chair of the FDA's Antimicrobial Drugs Advisory Committee criticized the agency's lack of a transparent, scientific process in approval of therapies to treat COVID-19, stating that "the trust the FDA has built and maintained over the past century is eroding." (New England Journal of Medicine)

How many pharmacies have had to borrow money to stay in business during the covid-19 pandemic? How many are in danger of failing, closing, having to file bankruptcy etc.?

How many independent pharmacy owners have had to take second jobs to payback these loans or make ends meet?


Note:  There are many states who have databases and other resources online to find out who received loans.